| 000 | 01513 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517123409.0 | ||
| 264 | 0 | _c20170310 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1744-764X | ||
| 024 | 7 |
_a10.1080/14740338.2017.1257604 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoutkias, Vassilis G | |
| 245 | 0 | 0 |
_aExploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies. _h[electronic resource] |
| 260 |
_bExpert opinion on drug safety _cFeb 2017 |
||
| 300 |
_a113-124 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCardiotoxicity _xetiology |
| 650 | 0 | 4 |
_aCerebral Hemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aClozapine _xadverse effects |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
| 650 | 0 | 4 |
_aFactor Xa Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHaloperidol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInformation Storage and Retrieval |
| 650 | 0 | 4 | _aPharmacovigilance |
| 650 | 0 | 4 |
_aPyrazoles _xadverse effects |
| 650 | 0 | 4 |
_aPyridones _xadverse effects |
| 700 | 1 | _aLillo-Le Louët, Agnès | |
| 700 | 1 | _aJaulent, Marie-Christine | |
| 773 | 0 |
_tExpert opinion on drug safety _gvol. 16 _gno. 2 _gp. 113-124 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14740338.2017.1257604 _zAvailable from publisher's website |
| 999 |
_c26577416 _d26577416 |
||